Published in PLoS Negl Trop Dis on August 13, 2008
Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev (2012) 4.07
The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ (2013) 1.94
Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. PLoS Negl Trop Dis (2010) 1.60
Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz (2009) 1.45
The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. PLoS Pathog (2012) 1.41
Toxoplasmosis: a global threat. J Glob Infect Dis (2011) 1.19
Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med (2010) 1.13
Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis (2011) 1.09
First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis (2011) 1.02
Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection. Antimicrob Agents Chemother (2014) 1.02
Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels. PLoS Negl Trop Dis (2013) 1.01
Genetic characterization of Toxoplasma gondii revealed highly diverse genotypes for isolates from newborns with congenital toxoplasmosis in southeastern Brazil. J Clin Microbiol (2013) 1.01
Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg (2014) 0.96
Transcriptional analysis of murine macrophages infected with different Toxoplasma strains identifies novel regulation of host signaling pathways. PLoS Pathog (2013) 0.94
Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. J Infect Dis (2012) 0.93
Congenital toxoplasmosis--a report on the Danish neonatal screening programme 1999-2007. J Inherit Metab Dis (2010) 0.92
Congenital toxoplasmosis and prenatal care state programs. BMC Infect Dis (2014) 0.91
Cell death of gamma interferon-stimulated human fibroblasts upon Toxoplasma gondii infection induces early parasite egress and limits parasite replication. Infect Immun (2013) 0.89
Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels. Front Microbiol (2014) 0.84
Have it your way: how polymorphic, injected kinases and pseudokinases enable Toxoplasma to subvert host defenses. PLoS Pathog (2013) 0.83
Do the placental barrier, parasite genotype and Toll-like receptor polymorphisms contribute to the course of primary infection with various Toxoplasma gondii genotypes in pregnant women? Eur J Clin Microbiol Infect Dis (2013) 0.82
Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis. Cytokine (2014) 0.81
Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases. Acta Physiol (Oxf) (2015) 0.81
Antibiotics for human toxoplasmosis: a systematic review of randomized trials. Pathog Glob Health (2013) 0.81
Immune profiling of pregnant Toxoplasma-infected US and Colombia patients reveals surprising impacts of infection on peripheral blood cytokines. J Infect Dis (2014) 0.80
Real-time PCR as a prognostic tool for human congenital toxoplasmosis. J Clin Microbiol (2013) 0.79
Calomys callosus chronically infected by Toxoplasma gondii clonal type II strain and reinfected by Brazilian strains is not able to prevent vertical transmission. Front Microbiol (2015) 0.78
Serotyping of Toxoplasma gondii in cats (Felis domesticus) reveals predominance of type II infections in Germany. PLoS One (2013) 0.78
First study on seroepidemiology and isolation of Toxoplasma gondii in free-range chickens in the semi-arid region of Paraíba state, Brazil. Parasitol Res (2016) 0.77
Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination. MBio (2015) 0.77
MHC Class I Chain-Related Gene A Polymorphisms and Linkage Disequilibrium with HLA-B and HLA-C Alleles in Ocular Toxoplasmosis. PLoS One (2015) 0.77
Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosis. Mediators Inflamm (2014) 0.77
Ocular toxoplasmosis: susceptibility in respect to the genes encoding the KIR receptors and their HLA class I ligands. Sci Rep (2016) 0.75
Case report of a neonate with ocular toxoplasmosis due to congenital infection: estimation of the percentage of ocular toxoplasmosis in Greece caused by congenital or acquired infection. Clin Ophthalmol (2013) 0.75
A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis. BMC Res Notes (2015) 0.75
Toxoplasma Effectors Targeting Host Signaling and Transcription. Clin Microbiol Rev (2017) 0.75
Cat-rodent Toxoplasma gondii Type II-variant circulation and limited genetic diversity on the Island of Fernando de Noronha, Brazil. Parasit Vectors (2017) 0.75
Is reactivation of toxoplasmic retinochoroiditis associated to increased annual rainfall? Parasite (2013) 0.75
IgG Avidity Test in Congenital Toxoplasmosis Diagnoses in Newborns. Pathogens (2017) 0.75
Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis (2016) 0.75
Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature (2006) 4.50
Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science (2006) 4.23
Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis (2003) 2.73
Ocular toxoplasmosis. Br J Ophthalmol (1973) 2.60
Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet (1999) 2.54
Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int J Parasitol (2004) 2.54
The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol (1996) 2.47
An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol (1992) 2.41
Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet (2007) 2.37
Globalization and the population structure of Toxoplasma gondii. Proc Natl Acad Sci U S A (2006) 2.17
Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol (2004) 2.15
Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med (2002) 2.09
Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis (2006) 2.00
Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis (2006) 1.98
Tutorial in biostatistics. An introduction to hierarchical linear modelling. Stat Med (1999) 1.64
Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation. Infect Immun (2007) 1.51
Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology (1998) 1.50
Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG (2003) 1.47
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol (2005) 1.41
Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr (2005) 1.39
Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol (2000) 1.36
Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR-RFLP. Infect Genet Evol (2005) 1.35
Visual loss in uveitis of childhood. Br J Ophthalmol (2003) 1.33
A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol (2001) 1.32
Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis. J Clin Microbiol (2006) 1.31
High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol (2000) 1.30
Biologic and genetic comparison of Toxoplasma gondii isolates in free-range chickens from the northern Pará state and the southern state Rio Grande do Sul, Brazil revealed highly diverse and distinct parasite populations. Vet Parasitol (2006) 1.20
Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect (2003) 1.19
Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen (2007) 1.18
Prevalence of toxoplasma IgG among pregnant women in west London according to country of birth and ethnic group. BMJ (1993) 1.12
Characteristics of a pediatric low-vision population. J Pediatr Ophthalmol Strabismus (1998) 1.10
Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J (2000) 1.09
Multicenter evaluation of a fluorometric enzyme immunocapture assay to detect toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns. J Clin Microbiol (1996) 1.07
Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol (2001) 1.02
Prevalence of Toxoplasma gondii in cats from Colombia, South America and genetic characterization of T. gondii isolates. Vet Parasitol (2006) 1.01
Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG (2005) 0.99
A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A. J Infect Dis (2004) 0.96
Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am J Ophthalmol (2007) 0.93
Socioeconomic conditions as determining factors in the prevalence of systemic and ocular toxoplasmosis in Northeastern Brazil. Ophthalmic Epidemiol (2004) 0.91
Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics (2008) 0.89
Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol (2003) 4.13
Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg (2008) 2.66
Upper airway structure and body fat composition in obese children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2010) 2.55
Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci (2011) 2.45
IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest (2002) 2.38
Sleep-disordered breathing in a population-based cohort: behavioral outcomes at 4 and 7 years. Pediatrics (2012) 2.33
Surgical management of liver hydatid disease: subadventitial cystectomy versus resection of the protruding dome. World J Surg (2014) 2.04
Predictors of travel-related hepatitis A and B among native adult Danes: a nationwide case-control study. J Infect (2011) 1.93
Etiology of diarrhea in young children in Denmark: a case-control study. J Clin Microbiol (2005) 1.89
A primary protocol for the management of ear keloids: results of excision combined with intraoperative and postoperative steroid injections. Plast Reconstr Surg (2007) 1.78
Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial. BMJ (2008) 1.65
Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr (2005) 1.63
Management of imported malaria in Europe. Malar J (2012) 1.60
Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis J (2011) 1.57
Visual loss associated with pediatric uveitis in english primary and referral centers. Am J Ophthalmol (2003) 1.51
Age is an important determinant in humoral and T cell responses to immunization with hepatitis B surface antigen. Hum Vaccin Immunother (2013) 1.48
Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: an empiric study. Scand J Infect Dis (2005) 1.48
Rhino-sinus involvement in children with obstructive sleep apnea syndrome. Pediatr Pulmonol (2010) 1.46
Randomized, controlled trial of a prenatal and postnatal lactation consultant intervention on duration and intensity of breastfeeding up to 12 months. Pediatrics (2005) 1.45
Photographic and videographic assessment of the smile: objective and subjective evaluations of posed and spontaneous smiles. Am J Orthod Dentofacial Orthop (2013) 1.44
Hepatitis B immunization coverage and risk behaviour among Danish travellers: are immunization strategies based on single journey itineraries rational? J Infect (2009) 1.41
Immune choroiditis following contralateral acute retinal necrosis. Arch Ophthalmol (2010) 1.40
Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr (2005) 1.39
Malaria chemoprophylaxis: strategies for risk groups. Clin Microbiol Rev (2008) 1.39
Interloop fluid in intussusception: what is its significance? Pediatr Radiol (2011) 1.39
Inequalities in provision of the Disability Living Allowance for Down syndrome. Arch Dis Child (2007) 1.39
Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz (2009) 1.39
Ocular features of Behcet's disease: an international collaborative study. Br J Ophthalmol (2007) 1.35
Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One (2008) 1.32
Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol (2004) 1.28
Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol (2003) 1.22
Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis. J Clin Microbiol (2005) 1.22
Maternal risk indicators for childhood caries in an inner city population. Community Dent Oral Epidemiol (2002) 1.21
Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine (2011) 1.19
Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen (2007) 1.18
Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products. J Clin Microbiol (2006) 1.17
Imported malaria in children in industrialized countries, 1992-2002. Emerg Infect Dis (2009) 1.15
IL-10 genotype analysis in patients with Behçet's disease. Hum Immunol (2006) 1.15
Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccines (2013) 1.13
Healthcare preferences of lesbian, gay, bisexual, transgender and questioning youth. J Adolesc Health (2009) 1.13
Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med (2010) 1.13
Prevalence and persistence of sleep disordered breathing symptoms in young children: a 6-year population-based cohort study. Sleep (2011) 1.13
The association of the PTPN22 620W polymorphism with Behcet's disease. Ann Rheum Dis (2007) 1.12
Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol (2008) 1.11
Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect (2006) 1.09
Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands. J Med Chem (2013) 1.09
Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients. J Clin Microbiol (2011) 1.09
Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J (2008) 1.09
Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. Int J Parasitol (2003) 1.08
Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun (2005) 1.07
The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes Infect (2004) 1.07
Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clin Vaccine Immunol (2010) 1.06
Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci (2004) 1.06
Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum (2003) 1.05
Ocular manifestations in congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol (2005) 1.04
Toxoplasma gondii isolates of free-ranging chickens from Rio de Janeiro, Brazil: mouse mortality, genotype, and oocyst shedding by cats. J Parasitol (2003) 1.04
Seizure clustering during epilepsy monitoring. Epilepsia (2002) 1.02
Acute pulmonary aspergillosis in immunocompetent subjects after exposure to bark chippings. Scand J Infect Dis (2006) 1.00
Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr (2005) 1.00
Reactivation of ocular toxoplasmosis during pregnancy. BJOG (2005) 0.98
Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome. Ophthalmology (2009) 0.98
The significance of baseline cerebral oxygen saturation in children undergoing congenital heart surgery. Am J Surg (2005) 0.98
Seroprevalence of human toxocariasis in Denmark. Clin Vaccine Immunol (2009) 0.97
Electrocardiograms transmitted via facsimile may not allow accurate interval interpretation. Pacing Clin Electrophysiol (2011) 0.97
The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. J Travel Med (2003) 0.96
Hepatitis A among Danish travellers 1980-2007. J Infect (2008) 0.95
Is functional MR imaging assessment of hemispheric language dominance as good as the Wada test?: a meta-analysis. Radiology (2011) 0.95
Randomized controlled trial of a prenatal and postnatal lactation consultant intervention on infant health care use. Arch Pediatr Adolesc Med (2006) 0.95
A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J Infect Dis (2005) 0.95
Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases. Eur J Obstet Gynecol Reprod Biol (2006) 0.95
Host genetic and epigenetic factors in toxoplasmosis. Mem Inst Oswaldo Cruz (2009) 0.95
Automated time-resolved immunofluorometric assay for Toxoplasma gondii-specific IgM and IgA antibodies: study of more than 130,000 filter-paper blood-spot samples from newborns. Clin Chem (2002) 0.94
Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur J Obstet Gynecol Reprod Biol (2007) 0.94
Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur J Immunol (2003) 0.94
Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine (2013) 0.93
Variation in the structure of Toxoplasma gondii and the roles of selfing, drift, and epistatic selection in maintaining linkage disequilibria. Infect Genet Evol (2004) 0.93
Dehydration is a risk factor for central retinal vein occlusion in young patients. Acta Ophthalmol Scand (2003) 0.93
Congenital toxoplasmosis. Handb Clin Neurol (2013) 0.93
Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clin Vaccine Immunol (2012) 0.93
Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis. Am J Ophthalmol (2007) 0.93
Increased CD154 expression in uninfected infants born to HIV-positive mothers exposed to antiretroviral prophylaxis. Viral Immunol (2006) 0.93
Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. J Infect Dis (2012) 0.93
Congenital toxoplasmosis--a report on the Danish neonatal screening programme 1999-2007. J Inherit Metab Dis (2010) 0.92
Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis. Antimicrob Agents Chemother (2004) 0.91
Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women. Clin Diagn Lab Immunol (2004) 0.91